FDA approves Boehringer Ingelheim, Eli Lilly’s Synjardy
Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have received approval from the Food and Drug Administration for Synjardy tablets, a medication for type 2 diabetes.
Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have received approval from the Food and Drug Administration for Synjardy tablets, a medication for type 2 diabetes.
Alvogen has entered an agreement to buy a portfolio of four U.S. pharmaceutical products from Pfizer Inc. Under the deal announced Wednesday, Alvogen plans to acquire three injectable products — Clindamycin, Voriconazole and Melphalan — and one inhaled solution product, Acetylcysteine.
Heartland Food Products Group plans to acquire the Splenda low-calorie sweetener brand from McNeil Nutritionals LLC, a subsidiary of Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Heartland said the transaction is slated to close before the end of this year.
The National Association of Chain Drug Stores has announced the winners of the 2015 NACDS Total Store Expo Product Showcase.
Amneal Pharmaceuticals LLC has formed Amneal Biosciences, a new business unit.
Ateb Inc. this week kicked off its first branding campaign, dubbed “Driving Healthy Outcomes for Patients, Pharmacies and Payers.
Rusty Field, chief commercial officer at Upsher-Smith Laboratories Inc., has been appointed as president of the company. Upsher-Smith said Monday that in the new role, Field will be responsible for delivering revenue and profitability to meet the pharmaceutical company’s growth objectives.
Connected care solution provider HealthSpot aims to bring rapid lab tests to retail pharmacy clinics via new technology from Samsung.
i-Health Inc. has released Culturelle Advanced Immune Defense, described as the first supplement with a triple-action immune boosting formula strengthened by probiotics.
Pharmaceutical inventory management solution provider Supplylogix is slated to debut its new Pinpoint Performance reporting module at the 2015 National Association of Chain Drug Stores Total Store Expo. The McKesson Corp.
Growth of the U.S. over-the-counter medications market has been primarily driven by prescription-to-OTC switches And that expansion is likely to continue. Due to an increasingly favorable regulatory environment, Kline & Co.
Camber Pharmaceuticals Inc. has launched entecavir tablets, an antiviral medication. Camber said Friday that its entecavir product is available in 30- and 90-count bottle for the 0.5-mg strength and in 30-count bottles for the 1-mg dosage.
Galderma Laboratories has released Epiduo Forte Gel, a once-daily topical acne treatment, to retail pharmacies nationwide and in Puerto Rico. The medication, adapalene and benzoyl peroxide 0.3%/2.5%, received Food and Drug Administration approval last month.
Valeant Pharmaceuticals International Inc. plans to acquire Sprout Pharmaceuticals Inc., the maker of a just-approved drug for sexual desire disorder in women, for about $1 billion in cash.
NBTY Inc. has hired former Coca-Cola executive Sonya Soutus to the newly created position of senior vice president of public affairs and communications.
PharmaSmart International Inc. and Chain Drug Review have teamed up to help pharmacists help their patients lower their blood pressure.